B · Normal
[CRO concept fluctuated and fell, Medicilon and Yaokang Biotech both fell by more than 10%] On October 13th, the CRO concept fluctuated and fell in early trading. Medicilon and Yaokang Biotech fell by more than 10%, and stocks such as Baicheng Pharmaceutical, Novozyme, Betta Pharmaceuticals, Boji Pharmaceutical, and Hongbo Pharmaceutical fell by more than 6%.
Comments